Barriers and potential solutions to providing optimal guideline-driven care to patients with diabetes in the U.S.

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3843-3849

  Vigersky, Robert A ^a   Fitzner, Karen ^b   Levinson, Jenifer ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b DEPAUL UNIVERSITY   (United States)

^c Avalere Health LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; INSULIN; METFORMIN;

CLINICAL PRACTICE; DIABETES EDUCATION; DIABETES MELLITUS; DIABETIC PATIENT; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MANAGED CARE ORGANIZATION; PRACTICE GUIDELINE; PROCESS OPTIMIZATION; REIMBURSEMENT; REVIEW; UNITED STATES; DIABETES COMPLICATIONS; ECONOMICS; PREVALENCE; STATISTICAL MODEL; TRENDS;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MODELS, ECONOMIC; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; UNITED STATES;

EID: 84891884528     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0680     Document Type: Review

References (43)

1. 2011 National Diabetes Fact Sheet [Internet], 2011. Available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed 28 December 2011
2. Huang, ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009;32:2225-2229
3. Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-2094
4. AmericanDiabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837- 853
7. UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998;317:720-726
8. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31:81-86
9. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:2542- 2551
10. Choe HM, Townsend KA, Blount G, Lo CH, Sadowski L, Standiford CJ. Treatment and control of blood pressure in patients with diabetes mellitus. Am J Health Syst Pharm 2007;64:97-103
11. American Association of Clinical Endocrinologists. Diabetes mellitus guideline. Endocr Pract 2007;13(Suppl. 1)
12. American Diabetes Association. Standards of medical care in diabetesd2013. Diabetes Care 2013;36(Suppl. 1):S11-S66
13. Cryer PE, Axelrod L, Grossman AB, et al.; Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709-728
14. Medical Group Management Association. Cost Survey: 2009 Report Based on 2008 Data. Englewood, CO, 2010
15. U.S. Bureau of Labor Statistics. Occupational employment statistics, healthcare practitioner and technical occupations [Internet], May 2012. Available from http://www.bls.gov/oes/current/oes-nat.htm#29- 0000. Accessed 10 June 2013
16. Ratanawongasa N, Karter AJ, Parker MM, et al. Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Intern Med 2013;173:210-218
17. Kurtz SMS. Adherence to diabetes regimens: empirical status and clinical applications. Diabetes Educ 1990;16:50-59
18. FunnellMM, Anderson RM.MSJAMA: the problem with compliance in diabetes. JAMA 2000;284:1709
19. Centers for Disease Control and Prevention. Team Care: Comprehensive Lifetime Management for Diabetes. Atlanta, GA, U.S. Department of health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 2001
20. Tao D, Or CK. Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials. J Telemed Telecare. 5 April 2013 [Epub ahead of print]
21. Misono AS, Cutrona SL, Choudhry NK, et al. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care 2010;16(Suppl. HIT):SP82- SP92
22. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34:1934-1942
23. Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006;23:1332-1338
24. Kim HS. A randomized controlled trial of a nurse short-message service by cellular phone for people with diabetes. Int J Nurs Stud 2007;44:687-692
25. Bell AM, Fonda SJ, Walker MS, Schmidt V, Vigersky RA. Mobile phone-based video messages for diabetes self-care support. J Diabetes Sci Tech 2012;6:310-319
26. Hufstader M, Swain M, Furukawa MF. State variation in e-prescribing trends in the United States [article online], 2012. Washington, DC, Office of the National Coordinator for Health Information Technology. Available from http://www.healthit.gov/sites/default/files/us-eprescribingtrends- onc-brief-4-nov2012 .pdf. Accessed 23 January 2013
27. Johnson KB, Lehmann CU; Council on Clinical Information Technology of the American Academy of Pediatrics. Electronic prescribing in pediatrics: toward safer and more effective medication management. Pediatrics 2013;131e1350-e1367
28. Warren J, Kennelly J, Warren D, et al. Using the general practice EMR for improving blood pressure medication adherence. Stud Health Technol Inform 2012;178:228-234
29. Centers for Medicare & Medicaid Services. FQHC advanced primary care practice demonstration. Available from http://innovation.cms.gov/initiatives/ fqhcs/. Accessed 9 August 2013
30. Grumbach K, Grundy P. Outcomes of implementing patient centered medical home interventions: a review of the evidence from prospective evaluation studies in the United States [article online], 2010. Patient-Centered Primary Care Collaborative. Available from http://dhhs.nv .gov/HealthCare/Docs/MedicalHomes/ Outcomes%20of%20Implementing%20Medical%20Home%20Interventions%20by%20the%20PCPC C%20-%20Nov%202010.pdf. Accessed 10 June 2013
31. McClellan M, McKethan AN, Lewis JL, Roski J, Fisher ES. A national strategy to put accountable care into practice. Health Aff (Millwood) 2010;29:982-990
32. Beck JK, Logan KJ, Hamm RM, et al. Reimbursement for pediatric diabetes intensive case management: a model for chronic diseases? Pediatrics 2004;113:e47-e50
33. De Brantes F, Rosenthal MB, Painter M. Building a bridge from fragmentation to accountabilitydthe Prometheus payment model. N Eng J Med 2009;361:1033-1036
34. Carroll J. Lessons learned in building the patient-centered medical home [article online], 2010. Available from http://www.managedcaremag.com/archives/ 1008/1008.medicalhome.html. Accessed 10 June 2013
35. Patient-Centered Primary Care Collaborative. Practices in the spotlight: the medical home and diabetes care [article online]. http://www.pcpcc.org/guide/ practices-spotlight. Accessed 29 December 2011
36. Naik AD, Palmer N, Petersen NJ, et al. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med 2011;171:453-459
37. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med 2010;152:689-696
38. Stewart AF. The United States endocrinology workforce: a supply-demand mismatch. J Clin Endocrinol Metab 2008;93: 1164-1166
39. National Health Service Corps. Pay off your student loans while serving communities in need [article online]. Available from http://nhsc.hrsa.gov/ loanrepayment/index.html. Accessed 2 May 2013
40. Pathman DE, Taylor DH Jr, Konrad TR, et al. State scholarship, loan forgiveness, and related programs: the unheralded safety net. JAMA 2000;284:2084-2092
41. Pathman DE, Konrad TR. Growth and changes in the National Health Service Corps (NHSC) workforce with the American Recovery and Reinvestment Act. J AmBoard FamMed 2012;25:723- 733
42. Bärnighausen T, Bloom DE. Financial incentives for return of service in underserved areas: a systematic review. BMC Health Serv Res 2009;9:86
43. Thaker SI, Pathman DE, Mark BA, Ricketts TC 3rd. Service-linked scholarships, loans, and loan repayment programs for nurses in the Southeast. J ProfNurs 2008;24:122-130